2. Academic Validation
  3. Antitumor activity of pyrindamycins A and B

Antitumor activity of pyrindamycins A and B

  • J Antibiot (Tokyo). 1989 Nov;42(11):1713-7. doi: 10.7164/antibiotics.42.1713.
S Ishii 1,  M Nagasawa,  Y Kariya,  H Yamamoto,  S Inouye,  S Kondo
Affiliations

Affiliation

  • 1 Pharmaceutical Research Laboratory, Meiji Seika Kaisha, Ltd., Yokohama, Japan.
PMID: 2531136 DOI: 10.7164/antibiotics.42.1713
Abstract

Pyrindamycins A(1) and B(2) exhibited stronger cytotoxic activities than doxorubicin towards murine and human tumor cell lines and especially towards doxorubicin-resistant cells. Pyrindamycins A and B were also active in vivo against P388/ADR, a multidrug-resistant tumor cell line. Intracellular accumulation of pyrindamycins A and B in P388/ADR was the same as in P388. These Antibiotics strongly inhibited DNA synthesis compared with RNA or protein synthesis. They showed significant therapeutic effects towards murine leukemia, but not to solid tumors.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z